drugset / Trial / NCT01091974

Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy

NCT01091974 ↗

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

This is a four-arm, randomized, controlled, clinical trial examining the efficacy of of cognitive behavioral therapy (CBT)-I and armodafinil in reducing insomnia in 226 female breast cancer patients who report sleep disturbances following completion of chemotherapy.

Timeline

Start
2008-02
Primary completion
2013-04
Completion
2013-04

Outcome

Met primary endpoint

paper both the CBT-I plus A (P = .001) and CBT-I plus P (P = .010) groups had significantly greater reductions in insomnia severity postintervention than the P group PMID 25452447 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Armodafinil Small molecule 100 mg Oral

Indications